Jingjia Li

Jingjia (Ginger) Li is an experienced investment professional with a diverse background in healthcare and M&A. Currently involved in healthcare investment at China Investment Corporation since July 2018, Jingjia previously contributed to business development at Pfizer from 2012 to July 2018, focusing on partnerships to expand the company's pipeline in China. Earlier roles include serving as a Senior Manager in advisory at PwC, where Jingjia provided consultancy on M&A strategy and execution, and as an Investment Professional at Quad-C Management, Inc., handling various aspects of the investment process. Prior experience also includes a Senior Consultant position at Strategy& and a Senior Analyst role at KPMG UK, specializing in transaction services. Jingjia holds a Master of Science in Operational Research from The University of Edinburgh and dual Bachelor's degrees in Civil Engineering and International Economics & Trade from Shanghai Jiao Tong University.